
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Our 340B experts explore ways to identify gaps in your 340B performance and offer solutions.
Date
May 19, 2022
By: Christopher Shain, Heather Easterling and Andrew Wilson
Read time: 1 minute
Many health systems may struggle to manage their 340B business performance because understanding their metrics requires data and analysis that aren’t easily available. Watch the 340B Tips, Tricks, and Traps webinar as we explore ways to leverage analytics with revenue cycle and generics purchasing to identify gaps in your 340B performance that can help you make informed decisions.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
As the infusion services market continues to evolve and challenge one of health systems’ longstanding service lines – new opportunities are also emerging.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.
Learn how McKesson is helping advance the 340B program through strategic customer engagement and insights.
AI data mining can be a powerful tool to help clinicians and researchers make successful matches.
Explore key trends and strategic recommendations from our experts to help you achieve more.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel they have.
Experts highlighted McKesson’s solutions to help health systems achieve more for the business of pharmacy.